| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dronedarone | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.29 | approved | antagonist |
| dronedarone | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| dronedarone | alpha-1d adrenergic receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| dronedarone | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| dronedarone | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| dronedarone | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| dronedarone | beta-1 adrenergic receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.35 | approved | antagonist |
| dronedarone | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit alpha-1f | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit beta-1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit beta-2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit beta-3 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-dependent l-type calcium channel subunit beta-4 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | voltage-gated potassium channel kv1.5 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.84 | approved | unknown |
| dronedarone | voltage-gated potassium channel kv1.5 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.84 | approved | inhibitor |
| dronedarone | potassium voltage-gated channel subfamily d member 3 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved | inhibitor |
| dronedarone | inward rectifier potassium channel | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | inward rectifier potassium channel | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | inward rectifier potassium channel | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | g protein-activated inward rectifier potassium channel 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | inward rectifier potassium channel | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | potassium channel subfamily k member 2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | potassium voltage-gated channel subfamily kqt member 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | sodium channel protein type 5 subunit alpha | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | sodium/calcium exchanger 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| dronedarone | thyroid hormone receptor alpha | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Atrial Fibrillation[MeSHID:D001281] pathologic fistula[MeSHID:D005402] Hospitalization[MeSHID:D006760] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| click here to return to the previous page | ||||||||